Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sarah Naomi Bolz & Michael Schroeder. (2023) Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances. Expert Opinion on Drug Discovery 18:9, pages 973-985.
Read now
Read now
Md Ataul Islam & Tahir S. Pillay. (2020) Identification of promising anti-DNA gyrase antibacterial compounds using de novo design, molecular docking and molecular dynamics studies. Journal of Biomolecular Structure and Dynamics 38:6, pages 1798-1809.
Read now
Read now
Agata Paneth, Paweł Stączek, Tomasz Plech, Aleksandra Strzelczyk, Katarzyna Dzitko, Monika Wujec, Edyta Kuśmierz, Urszula Kosikowska, Agnieszka Grzegorczyk & Piotr Paneth. (2016) Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 31:1, pages 14-22.
Read now
Read now
Articles from other publishers (49)
Vladimir Dobričić, Jelena Savić, Tihomir Tomašič, Martina Durcik, Nace Zidar, Lucija Peterlin Mašič, Janez Ilaš, Danijel Kikelj & Olivera Čudina. (2022) High-performance liquid chromatography evaluation of lipophilicity and QSRR modeling of a series of dual DNA gyrase and topoisomerase IV inhibitors. Acta Chromatographica.
Crossref
Crossref
Summaya Perveen & Rashmi Sharma. (2022) Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery. Biochemical Pharmacology 197, pages 114906.
Crossref
Crossref
Yinglin Xia & Jun Sun. 2022. Statistical Data Analysis of Microbiomes and Metabolomics. Statistical Data Analysis of Microbiomes and Metabolomics.
Abbas Kabir & Aaron Muth. (2022) Polypharmacology: The science of multi-targeting molecules. Pharmacological Research 176, pages 106055.
Crossref
Crossref
Filipe G. A. Estrada, Silvia Miccoli, Natália Aniceto, Alfonso T. García-Sosa & Rita C. Guedes. (2021) Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma. Molecules 26:18, pages 5574.
Crossref
Crossref
Suwon Kim, Seri Jo, Mi‐Sun Kim & Dong H. Shin. (2021)
A triple‐targeting inhibitory activity of Rose Bengal on polysaccharide biosynthesis of
Burkholderia pseudomallei
. Archiv der Pharmazie 354:6.
Crossref
Crossref
Martina Hrast, Rok Frlan, Damijan Knez, Irena Zdovc, Hélène Barreteau & Stanislav Gobec. (2021) Mur ligases inhibitors with azastilbene scaffold: Expanding the structure–activity relationship. Bioorganic & Medicinal Chemistry Letters 40, pages 127966.
Crossref
Crossref
Abdrrahman Shemsu Surur & Dianqing Sun. (2021) Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates. Frontiers in Chemistry 9.
Crossref
Crossref
Aleksandra Kowalczyk, Agata Paneth, Damian Trojanowski, Piotr Paneth, Jolanta Zakrzewska-Czerwińska & Paweł Stączek. (2021) Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis. International Journal of Molecular Sciences 22:8, pages 3881.
Crossref
Crossref
John BremnerJohn Bremner. 2021. Multiple Action-Based Design Approaches to Antibacterials. Multiple Action-Based Design Approaches to Antibacterials
51
119
.
Noraziah M. Zin, Muhanna M. Al-shaibani, Juriyati Jalil, Asif Sukri, Anis Rageh Al-Maleki & Nik Marzuki Sidik. (2020) Profiling of gene expression in methicillin-resistant Staphylococcus aureus in response to cyclo-(l-Val-l-Pro) and chloramphenicol isolated from Streptomyces sp., SUK 25 reveals gene downregulation in multiple biological targets. Archives of Microbiology 202:8, pages 2083-2092.
Crossref
Crossref
Giovanni Stelitano, José Camilla Sammartino & Laurent Roberto Chiarelli. (2020) Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis. Molecules 25:5, pages 1239.
Crossref
Crossref
. (2020) Mass spectrometry study of noncovalent complexes formation of antibiotic cycloserine with N-acetyl-D-glucosamine and ascorbic acid. Biophysical Bulletin:43.
Crossref
Crossref
Yongxi Dong, Xiaohe Zhang, Mingji Liu, Yang Yang, Ting Guo, Yuanhu Mao, Jiquan Zhang, Xiaozhong Fu, Yonglong Zhao, Jinglei Chen, Li Dong & Chunhua Qiao. (2019) Hybrid molecules of scutellarein and tertramethylpyrazine’s active metabolites for ischemic stroke. Bioorganic & Medicinal Chemistry Letters 29:19, pages 126608.
Crossref
Crossref
Elena González-Hernández, Rubén Aparicio, Mercedes Garayoa, M. José Montero, M. Ángeles Sevilla & Concepción Pérez-Melero. (2019) Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents. MedChemComm 10:9, pages 1589-1598.
Crossref
Crossref
Gabriele Magarò, Federica Prati, Barbara Garofalo, Gaia Corso, Guido Furlotti, Claudia Apicella, Giorgina Mangano, Noemi D’Atanasio, Daniel Robinson, Francesco Paolo Di Giorgio & Rosella Ombrato. (2019) Virtual Screening Approach and Investigation of Structure–Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens. Journal of Medicinal Chemistry 62:16, pages 7445-7472.
Crossref
Crossref
V. Kartsev, Khidmet S. Shikhaliev, A. Geronikaki, Svetlana M. Medvedeva, Irina V. Ledenyova, Mikhail Yu Krysin, A. Petrou, A. Ciric, J. Glamoclija & M. Sokovic. (2019) Appendix A. dithioloquinolinethiones as new potential multitargeted antibacterial and antifungal agents: Synthesis, biological evaluation and molecular docking studies. European Journal of Medicinal Chemistry 175, pages 201-214.
Crossref
Crossref
Ewgenij Proschak, Holger Stark & Daniel Merk. (2018) Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds. Journal of Medicinal Chemistry 62:2, pages 420-444.
Crossref
Crossref
Wouter J.C. de Bruijn, Jos A. Hageman, Carla Araya-Cloutier, Harry Gruppen & Jean-Paul Vincken. (2018) QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives. Bioorganic & Medicinal Chemistry 26:23-24, pages 6105-6114.
Crossref
Crossref
Charles R. Dean, David T. Barkan, Alun Bermingham, Johanne Blais, Fergal Casey, Anthony Casarez, Richard Colvin, John Fuller, Adriana K. Jones, Cindy Li, Sara Lopez, Louis E. MetzgerIVIV, Mina Mostafavi, Ramadevi Prathapam, Dita Rasper, Folkert Reck, Alexey Ruzin, Jacob Shaul, Xiaoyu Shen, Robert L. Simmons, Peter Skewes-Cox, Kenneth T. Takeoka, Pramila Tamrakar, Tsuyoshi Uehara & Jun-Rong Wei. (2018)
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing
In Vitro
Susceptibility in Escherichia coli and Klebsiella pneumoniae
. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Crossref
Michaela Barančoková, Danijel Kikelj & Janez Ilaš. (2018) Recent progress in the discovery and development of DNA gyrase B inhibitors. Future Medicinal Chemistry 10:10, pages 1207-1227.
Crossref
Crossref
Folkert Reck, Alun Bermingham, Johanne Blais, Vladimir Capka, Taryn Cariaga, Anthony Casarez, Richard Colvin, Charles R. Dean, Alex Fekete, Wanben Gong, Ellie Growcott, Hongqiu Guo, Adriana K. Jones, Cindy Li, Fengxia Li, Xiaodong Lin, Mika Lindvall, Sara Lopez, David McKenney, Louis Metzger, Heinz E. Moser, Ramadevi Prathapam, Dita Rasper, Patrick Rudewicz, Vijay Sethuraman, Xiaoyu Shen, Jacob Shaul, Robert L. Simmons, Kyuto Tashiro, Dazhi Tang, Meiliana Tjandra, Nancy Turner, Tsuyoshi Uehara, Charles Vitt, Steven Whitebread, Aregahegn Yifru, Xu Zang & Qingming Zhu. (2018) Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228. Bioorganic & Medicinal Chemistry Letters 28:4, pages 748-755.
Crossref
Crossref
Silvia T. Cardona, Matthew Choy & Andrew M. Hogan. (2017) Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies. The Journal of Membrane Biology 251:1, pages 75-89.
Crossref
Crossref
Sarah Batson, Cesira de Chiara, Vita Majce, Adrian J. Lloyd, Stanislav Gobec, Dean Rea, Vilmos Fülöp, Christopher W. Thoroughgood, Katie J. Simmons, Christopher G. Dowson, Colin W. G. Fishwick, Luiz Pedro S. de Carvalho & David I. Roper. (2017) Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine. Nature Communications 8:1.
Crossref
Crossref
Sherine E. Thomas, Vitor Mendes, So Yeon Kim, Sony Malhotra, Bernardo Ochoa-Montaño, Michal Blaszczyk & Tom L. Blundell. (2017) Structural Biology and the Design of New Therapeutics: From HIV and Cancer to Mycobacterial Infections. Journal of Molecular Biology 429:17, pages 2677-2693.
Crossref
Crossref
Sheo B. Singh, Katherine Young & Lynn L. Silver. (2017) What is an “ideal” antibiotic? Discovery challenges and path forward. Biochemical Pharmacology 133, pages 63-73.
Crossref
Crossref
Philippe Panchaud, Thierry Bruyère, Anne-Catherine Blumstein, Daniel Bur, Alain Chambovey, Eric A. Ertel, Markus Gude, Christian Hubschwerlen, Loïc Jacob, Thierry Kimmerlin, Thomas Pfeifer, Lars Prade, Peter Seiler, Daniel Ritz & Georg Rueedi. (2017) Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents. Journal of Medicinal Chemistry 60:9, pages 3755-3775.
Crossref
Crossref
Cédric Charrier, Anne-Marie Salisbury, Victoria J. Savage, Thomas Duffy, Emmanuel Moyo, Nathan Chaffer-Malam, Nicola Ooi, Rebecca Newman, Jonathan Cheung, Richard Metzger, David McGarry, Mark Pichowicz, Ralph Sigerson, Ian R. Cooper, Gary Nelson, Hayley S. Butler, Mark Craighead, Andrew J. Ratcliffe, Stuart A. Best & Neil R. Stokes. (2017) Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria. Antimicrobial Agents and Chemotherapy 61:5.
Crossref
Crossref
Jed F. Fisher, Jarrod W. Johnson & Shahriar Mobashery. 2017. Handbook of Antimicrobial Resistance. Handbook of Antimicrobial Resistance
231
261
.
Muhammad Jawad Ahmad, Syed Fahad Hassan, Riffat Un Nisa, Khurshid Ayub, Muhammad Shahid Nadeem, Samina Nazir, Farzana Latif Ansari, Naveeda Akhtar Qureshi & Umer Rashid. (2016) Synthesis, in vitro potential and computational studies on 2-amino-1, 4-dihydropyrimidines as multitarget antibacterial ligands. Medicinal Chemistry Research 25:9, pages 1877-1894.
Crossref
Crossref
Rebecca E. Hughes, Katarina Nikolic & Rona R. Ramsay. (2016) One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug. Frontiers in Neuroscience 10.
Crossref
Crossref
Xinxin FengWei Zhu, Lici A. Schurig-BriccioSteffen LindertCarolyn ShoenReese HitchingsJikun LiYang WangNoman BaigTianhui ZhouBoo Kyung KimDean C. CrickMichael CynamonJ. Andrew McCammonRobert B. Gennis & Eric Oldfield. (2015) Antiinfectives targeting enzymes and the proton motive force. Proceedings of the National Academy of Sciences 112:51.
Crossref
Crossref
Nilay Budeyri GokgozBerna Sariyar Akbulut. (2015) Proteomics Evidence for the Activity of the Putative Antibacterial Plant Alkaloid (-)-Roemerine: Mainstreaming Omics-Guided Drug Discovery. OMICS: A Journal of Integrative Biology 19:8, pages 478-489.
Crossref
Crossref
Jed Fisher & Shahriar Mobashery. 2015. Practical Handbook of Microbiology, Third Edition. Practical Handbook of Microbiology, Third Edition
221
264
.
Tess M. Eidem, Nicole Lounsbury, John F. Emery, Jeffrey Bulger, Andrew Smith, Magid Abou-Gharbia, Wayne Childers & Paul M. Dunman. (2015) Small-Molecule Inhibitors of Staphylococcus aureus RnpA-Mediated RNA Turnover and tRNA Processing. Antimicrobial Agents and Chemotherapy 59:4, pages 2016-2028.
Crossref
Crossref
Major Gooyit, Nancy Tricoche, Sacha Javor, Sara Lustigman & Kim D. Janda. (2015)
Exploiting the Polypharmacology of ß-Carbolines to Disrupt
O. volvulus
Molting
. ACS Medicinal Chemistry Letters 6:3, pages 339-343.
Crossref
Crossref
Gerard D. Wright. (2015) Solving the Antibiotic Crisis. ACS Infectious Diseases 1:2, pages 80-84.
Crossref
Crossref
Jean-Philippe Surivet, Cornelia Zumbrunn, Georg Rueedi, Daniel Bur, Thierry Bruyère, Hans Locher, Daniel Ritz, Peter Seiler, Christopher Kohl, Eric A. Ertel, Patrick Hess, Jean-Christophe Gauvin, Azely Mirre, Verena Kaegi, Marina Dos Santos, Stéphanie Kraemer, Mika Gaertner, Jonathan Delers, Michel Enderlin-Paput, Maria Weiss, Romain Sube, Hakim Hadana, Wolfgang Keck & Christian Hubschwerlen. (2014) Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram Positive Activity and Improved Safety Profile. Journal of Medicinal Chemistry 58:2, pages 927-942.
Crossref
Crossref
Pamela Brown & Michael J. Dawson. 2015.
135
184
.
Eric Oldfield & Xinxin Feng. (2014) Resistance-resistant antibiotics. Trends in Pharmacological Sciences 35:12, pages 664-674.
Crossref
Crossref
Molly A. Silvers, Gregory T. Robertson, Carol M. Taylor & Grover L. Waldrop. (2014) Design, Synthesis, and Antibacterial Properties of Dual-Ligand Inhibitors of Acetyl-CoA Carboxylase. Journal of Medicinal Chemistry 57:21, pages 8947-8959.
Crossref
Crossref
Imène Kouidmi, Roger C. Levesque & Catherine Paradis-Bleau. (2014) The biology of Mur ligases as an antibacterial target. Molecular Microbiology 94:2, pages 242-253.
Crossref
Crossref
Pooja Gopal & Thomas Dick. (2014) Reactive dirty fragments: implications for tuberculosis drug discovery. Current Opinion in Microbiology 21, pages 7-12.
Crossref
Crossref
Gregory S. Basarab, Pamela J. Hill, C. Edwin Garner, Ken Hull, Oluyinka Green, Brian A. Sherer, P. Brian Dangel, John I. Manchester, Shanta Bist, Sheila Hauck, Fei Zhou, Maria Uria-Nickelsen, Ruth Illingworth, Richard Alm, Mike Rooney & Ann E. Eakin. (2014) Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099). Journal of Medicinal Chemistry 57:14, pages 6060-6082.
Crossref
Crossref
Jed F. Fisher, Jarrod W. Johnson & Shahriar Mobashery. 2014. Handbook of Antimicrobial Resistance. Handbook of Antimicrobial Resistance
1
29
.
Neil R. Stokes, Helena B. Thomaides-Brears, Stephanie Barker, James M. Bennett, Joanne Berry, Ian Collins, Lloyd G. Czaplewski, Vicki Gamble, Paul Lancett, Alastair Logan, Christopher J. Lunniss, Hilary Peasley, Stéphanie Pommier, Daniel Price, Carol Smee & David J. Haydon. (2013) Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases. Antimicrobial Agents and Chemotherapy 57:12, pages 5977-5986.
Crossref
Crossref
Jens-Uwe Peters. (2013) Polypharmacology – Foe or Friend?. Journal of Medicinal Chemistry 56:22, pages 8955-8971.
Crossref
Crossref
Jean-Philippe Surivet, Cornelia Zumbrunn, Georg Rueedi, Christian Hubschwerlen, Daniel Bur, Thierry Bruyère, Hans Locher, Daniel Ritz, Wolfgang Keck, Peter Seiler, Christopher Kohl, Jean-Christophe Gauvin, Azely Mirre, Verena Kaegi, Marina Dos Santos, Mika Gaertner, Jonathan Delers, Michel Enderlin-Paput & Maria Boehme. (2013) Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity. Journal of Medicinal Chemistry 56:18, pages 7396-7415.
Crossref
Crossref
Eric D. Brown. (2013) Is the GAIN Act a turning point in new antibiotic discovery?. Canadian Journal of Microbiology 59:3, pages 153-156.
Crossref
Crossref